tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Teva reaffirms FY25 revenue view $16.8B-$17.2B, consensus $16.92B

Narrows diluted EPS view to $2.50-$2.65 from $2.45-$2.65, consensus $2.53. Sees Non-GAAP operating income of $4.3 – $4.6B; Adjusted EBITDA of $4.7 – $5B; Free cash flow of $1.6 – $1.9B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1